Bugnion SpA

Alessandro Cossu of Bugnion SpA examines the Unified Patent Court’s ‘holistic approach’ to inventive step, arguing that it departs from EPO practice, risks hindsight, and may undermine predictability and harmonisation in European patent law

Andrea Delbarba and Claudia Finetti of Bugnion SpA explain how supplementary protection certificates extend pharmaceutical patent protection, the role of paediatric extensions, and recent Italian clarifications on fees and regulatory processes

Vieri Canepele of Bugnion SpA examines a landmark Italian Supreme Court ruling on whether a patent co-owner may exploit a jointly owned invention without consent from fellow rights holders

Andrea Cappai of Bugnion SpA considers the strengths and weaknesses of GlobalBlock and GlobalBlock+ as trademark protection tools and draws comparisons with several other options in the quest for a unified solution

Stefano Ferro of Bugnion SpA explains the Italian legal position on inventions developed by private entities and those by universities or public research organisations, and suggests companies should consider modifying their most productive researchers’ contracts

Cristina Biggi of Bugnion shares her expertise on second medical use patents in Europe, focusing particularly on recent case law from Italy